SCHEMBL6975905

SCHEMBL6975905

O=C1CCCCC(CC2COc3ccccc3O2)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
ADRA2A P08913 2/20 0.43
ADRA1A P35348 2/20 0.43
HTT P42858 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1B P35368 1/20 0.43
SCN1A P35498 1/20 0.43
SCN2A Q99250 1/20 0.43
SCN3A Q9NY46 1/20 0.43
CA2 P00918 3/20 0.41
MTNR1A P48039 1/20 0.41
ALOX5 P09917 1/20 0.40
HTR1A P08908 1/20 0.40
DRD1 P21728 1/20 0.40
TBXA2R P21731 1/20 0.40
SLC6A2 P23975 1/20 0.40
DRD3 P35462 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6974616 0.85 ADRA2A (0.43) TSHRADRA2AADRA1AHTTADRA2B
SCHEMBL6980321 0.76 ADRA2A (0.45) TSHRADRA2AADRA1AHTTADRA2B
SCHEMBL6974131 0.76 TP53 (0.31)
SCHEMBL4019894 0.72 CRBN (0.36) CA2
SCHEMBL6969454 0.69 ALDH1A1 (0.42) KDM4E
SCHEMBL6976839 0.69 ALDH1A1 (0.37) TSHRHTTKDM4E
SCHEMBL31040258 0.68 ADRA2A (0.56) TSHRADRA2AADRA1AADRA2BADRA2C
SCHEMBL1568315 0.67 HTT (0.60) ADRA2AADRA1AHTTADRA2BADRA2C
SCHEMBL2204596 0.67 ADRA2A (0.56) ADRA2AADRA1AHTTADRA2BADRA2C
SCHEMBL23459341 0.67 CTSD (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821674-B1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2003-08-06 EP disclosed
US-6043261-A TREATMENT OF INFLAMMATORY CONDITIONS AFFECTING THE JOINTS, FOR EXAMPLE ARTHRITIS, INFLAMMATORY BOWEL DISEASE, CARDIOVASCULAR ISCHEMIA, DIABETES, HYPERALGESIA, CEREBRAL ISCHEMIA, THROMBOTIC STROKE, GLOBAL ISCHEMIA, NERVOUS SYSTEM DISORDERS G. D. SEARLE & CO. (US) 2000-03-28 US disclosed
US-6011028-A Cyclic amidino agents useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 2000-01-04 US disclosed
US-5883251-A ENZYME INHIBITORS G. D. SEARLE & CO. (US) 1999-03-16 US disclosed
EP-0821674-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-02-04 EP disclosed
WO-1996033175-A1 CYCLIC AMIDINO AGENTS USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-10-24 WO disclosed